Top Institutions in Gene Editing and Genetic Therapies for Cystic Fibrosis
Leading institutions utilize CRISPR-based gene editing technologies, including base editors and Cas9 variants, combined with molecular engineering to enhance specificity and reduce off-target mutations in cystic fibrosis-related genes. They integrate molecular biology, bioengineering, and clinical translational research to develop and validate these tools in relevant human cell models.
-
#1
University of Pennsylvania
Philadelphia, PA
Pioneering work in engineering precise base editors for cystic fibrosis mutations, combining expertise in chemical and biomolecular engineering with translational gene therapy research. Their leadership in CRISPR technology development and application to CFTR gene editing is well recognized.
Key Differentiators
- Gene Editing
- Bioengineering
- Molecular Biology
- Cystic Fibrosis Research
-
#2
Rice University
Houston, TX
Collaborates closely with University of Pennsylvania on engineering molecular linkers and enzyme variants to improve base editor specificity, contributing significant expertise in molecular design and bioengineering.
Key Differentiators
- Bioengineering
- Molecular Engineering
- Gene Editing Technologies
-
#3
Broad Institute of MIT and Harvard
Cambridge, MA
Leading center for CRISPR and base editing technology development with extensive research on improving editing specificity and expanding therapeutic applications for genetic diseases including cystic fibrosis.
Key Differentiators
- Genome Editing
- CRISPR Technology
- Genomic Medicine
-
#4
University of California, San Francisco (UCSF)
San Francisco, CA
Strong translational research programs in cystic fibrosis and gene therapy, focusing on developing and testing novel gene editing tools in pulmonary disease models.
Key Differentiators
- Genetic Medicine
- Gene Therapy
- Pulmonology
-
#5
Johns Hopkins University
Baltimore, MD
Known for integrating genomic technologies with clinical research in cystic fibrosis, advancing gene editing approaches and functional assays to evaluate therapeutic efficacy.
Key Differentiators
- Genomic Medicine
- Gene Editing
- Pulmonary Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
